MHRA: Dialysis guidance (updated 21 June 2023)

Summary

Renal replacement therapy is treatment that are given to patients whose kidneys stop working properly, including chronic kidney disease and acute kidney injury. The therapy includes haemodialysis (HD), peritoneal dialysis (PD) and continuous renal replacement therapy (CRRT), sometimes referred to as haemofiltration.

This guidance has been produced in collaboration with the UK Kidney Patient Safety Committee, to summarise known safety issues with dialysis and CRRT and describe what to do to minimise or prevent serious injury.

This guidance is aimed mainly at healthcare professionals and patients who carry out their own dialysis. This guidance replaces the previous Dialysis Lessons Learn guidance published by the MHRA.